Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 73 of the 73 references it cites were found in a registry or an index.

Comparative Transcriptome Analysis Reveals That Exendin-4 Improves Steatosis in HepG2 Cells by Modulating Signaling Pathways Related to Lipid Metabolism

Open access
Errafii, Khaoula, Khalifa, Olfa, Al-Akl, Neyla S., Arredouani, Abdelilah · 2022 · Biomedicines

Abstract

No therapy exists for non-alcoholic fatty liver disease (NAFLD). However, glucagon-like peptide receptor agonists (GLP-1RAs) showed a beneficial effect on NAFLD, although the underpinning mechanisms remain unclear due to their pleiotropic effects. We examined the implicated signaling pathways using comparative transcriptomics in a cell model of steatosis to overcome pleiotropy. We treated steatotic HepG2 cells with the GLP-1RA Exendin-4 (Ex-4). We compared the transcriptome profiles of untreated steatotic, and Ex-4-treated steatotic cells, and used Ingenuity Pathway Analysis (IPA) to identify the signaling pathways and associated genes involved in the protective effect of Ex-4. Ex-4 treatment significantly reduces steatosis. RNA-seq analysis revealed 209 differentially expressed genes (DEGs) between steatotic and untreated cells, with farnesoid X receptor/retinoid X receptor (FXR/RXR) (p = 8.9 × 10−7) activation being the top regulated canonical pathway identified by IPA. Furthermore, 1644 DEGs were identified between steatotic cells and Ex-4-treated cells, with liver X receptor/retinoid X receptor (LXR/RXR) (p = 2.02 × 10−7) and FXR/RXR (p = 3.28 × 10−7) activation being the two top canonical pathways. The top molecular and cellular functions between untreated and steatotic cells were lipid metabolism, molecular transport, and small molecular biochemistry, while organismal injury and abnormalities, endocrine system disorders, and gastrointestinal disease were the top three molecular and cellular functions between Ex-4-treated and steatotic cells. Genes overlapping steatotic cells and Ex-4-treated cells were associated with several lipid metabolism processes. Unique transcriptomic differences exist between steatotic cells and Ex-4-treated steatotic cells, providing an important resource for understanding the mechanisms that underpin the protective effect of GLP-1RAs on NAFLD and for the identification of novel therapeutic targets for NAFLD.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3390/biomedicines10051020

Cites

73 of 73 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 Differentially expressed genes between untreated, steatotic, and Ex-4-treated steatotic cells. (A). Venn diagram showing the distribution of the genes affected by steatosis and the treatment with Ex-4 as determined by transcriptomics analysis. (B). Log2FC heatmap demonstrating overlap in DEG expression patterns in untreated steatotic, and Exendin-4 treated steatotic HepG2 cells. Rows and columns represent genes (1465) and samples, respectively. The heatmap is based on normalized gene expression (GE) values from each dataset. Dendrogram depicts hierarchical clustering of DEGs according to normalized GE values. The blue color indicates downregulated genes while the red indicates the upregulated genes. UCs: untreated cells; StCs: steatotic cells; EX-4-TStCs: Ex-4-treated steatotic cells. n = 3 for each condition.
Figure 1 Differentially expressed genes between untreated, steatotic, and Ex-4-treated steatotic cells. (A). Venn diagram showing the distribution of the genes affected by steatosis and the treatment with Ex-4 as determined by transcriptomics analysis. (B). Log2FC heatmap demonstrating overlap in DEG expression patterns in untreated steatotic, and Exendin-4 treated steatotic HepG2 cells. Rows and columns represent genes (1465) and samples, respectively. The heatmap is based on normalized gene expression (GE) values from each dataset. Dendrogram depicts hierarchical clustering of DEGs according to normalized GE values. The blue color indicates downregulated genes while the red indicates the upregulated genes. UCs: untreated cells; StCs: steatotic cells; EX-4-TStCs: Ex-4-treated steatotic cells. n = 3 for each condition.CC BY · PubMed Central
Figure 2 Transcriptome analysis of steatotic versus untreated cells. (A) Volcano plot showing that 209 mRNAs were statistically differentially regulated (black dots; ≥2-fold difference, adjusted p < 0.05), of which 51 were significantly upregulated and 158 significantly downregulated. (B) Top 15 individual up- and downregulated transcripts between StCs and UCs. (C) Top five up- and downregulated canonical pathways identified by IPA. (D) Top two canonical pathways identified by IPA using up- or downregulated genes and the number of molecules involved. The ratio indicates the number of genes in the analyzed data over the number of genes known to be involved in the pathway.
Figure 2 Transcriptome analysis of steatotic versus untreated cells. (A) Volcano plot showing that 209 mRNAs were statistically differentially regulated (black dots; ≥2-fold difference, adjusted p < 0.05), of which 51 were significantly upregulated and 158 significantly downregulated. (B) Top 15 individual up- and downregulated transcripts between StCs and UCs. (C) Top five up- and downregulated canonical pathways identified by IPA. (D) Top two canonical pathways identified by IPA using up- or downregulated genes and the number of molecules involved. The ratio indicates the number of genes in the analyzed data over the number of genes known to be involved in the pathway.CC BY · PubMed Central
Figure 3 Molecular and cellular functions related to NAFLD (A,B) Molecular and cellular functions potentially related to NAFLD identified with the down- (A) and up- (B) regulated DEGs between StCs and UCs datasets. (C,D) Molecular and cellular functions potentially related to NAFLD identified with the down- (C) and up- (D) regulated DEGs between StCs and Ex-4-TStCs datasets. The numbers between parentheses indicate the number of genes involved in each function.
Figure 3 Molecular and cellular functions related to NAFLD (A,B) Molecular and cellular functions potentially related to NAFLD identified with the down- (A) and up- (B) regulated DEGs between StCs and UCs datasets. (C,D) Molecular and cellular functions potentially related to NAFLD identified with the down- (C) and up- (D) regulated DEGs between StCs and Ex-4-TStCs datasets. The numbers between parentheses indicate the number of genes involved in each function.CC BY · PubMed Central
Figure 4 Transcriptome analysis of Ex-4TSC versus SC. (A) 1644 mRNAs were determined to be statistically differentially expressed (red dots: >2-fold difference, p < 0.05), of which 479 were significantly upregulated and 1165 significantly downregulated. (B) Top 15 individual up- and downregulated DEGs between Ex-4TSC and UC. (C) Top 5 up- and downregulated canonical pathways identified by IPA. (D) Top 2 canonical pathways identified by IPA using up- or downregulated genes and the number of molecules involved. The Venn diagram’s upward and downward arrows indicate upregulation and downregulation, respectively. The ratio indicates the number of genes in the analyzed data over the number of genes known to be involved in the pathway.
Figure 4 Transcriptome analysis of Ex-4TSC versus SC. (A) 1644 mRNAs were determined to be statistically differentially expressed (red dots: >2-fold difference, p < 0.05), of which 479 were significantly upregulated and 1165 significantly downregulated. (B) Top 15 individual up- and downregulated DEGs between Ex-4TSC and UC. (C) Top 5 up- and downregulated canonical pathways identified by IPA. (D) Top 2 canonical pathways identified by IPA using up- or downregulated genes and the number of molecules involved. The Venn diagram’s upward and downward arrows indicate upregulation and downregulation, respectively. The ratio indicates the number of genes in the analyzed data over the number of genes known to be involved in the pathway.CC BY · PubMed Central
Figure 5 Venn diagram (A) and bar graph (B) depicting the overlapped DEGs between steatotic cells and Exendin-4 treated steatotic HepG2 cells. The blue color indicates downregulation, while the magenta color indicates upregulation.
Figure 5 Venn diagram (A) and bar graph (B) depicting the overlapped DEGs between steatotic cells and Exendin-4 treated steatotic HepG2 cells. The blue color indicates downregulation, while the magenta color indicates upregulation.CC BY · PubMed Central
Figure 6 Significant canonical pathways (A), cellular and molecular functions (B), and lipid metabolism pathways (C), enriched with the 31 overlapping genes between StCs and Ex-4TStCs.
Figure 6 Significant canonical pathways (A), cellular and molecular functions (B), and lipid metabolism pathways (C), enriched with the 31 overlapping genes between StCs and Ex-4TStCs.CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 73 references

Cited by

See all 17

Metadata

Authors
Errafii, K., Khalifa, O., Al-Akl, N. S., & Arredouani, A.
Affiliations
  • College of Health and Life Sciences, Hamad Bin Khalifa University, Qatar Foundation, Doha P.O. Box 34110, Qatar
  • Hamad bin Khalifa University (QA)
Corresponding author
Arredouani, Abdelilah
Venue
Biomedicines
Publisher
MDPI AG
Published
2022-04-28
Volume
10
Issue
5
Pages
1020
ISSN
2227-9059 (ISSN-L)
OpenAlex
W4225115625
Cited by
17
References
73
Citations by year
2026: 4 · 2025: 4 · 2024: 4 · 2023: 5
FWCI
2.35
Type
journal article
Language
en
Open access
Locations
  • Biomedicines (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
  • Figshare (submittedVersion, cc-by)
Funders
Qatar Biomedical Research Institute (VR93)
Topics
  • Health Sciences › Medicine › Hepatology › Liver Disease Diagnosis and Treatment
  • Health Sciences › Medicine › Hepatology › Liver physiology and pathology
  • Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmacology › Drug-Induced Hepatotoxicity and Protection
Keywords
exendin-4, non-alcoholic fatty liver disease, hepatic steatosis, GLP-1 receptor agonists, HepG2 cells, lipid metabolism, differentially expressed genes, transcriptome, therapeutic target

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Comparative Transcriptome Analysis Reveals That Exendin-4 Improves Steatosis in HepG2 Cells by Modulating Signaling Pathways Related to Lipid Metabolism. https://app.cochat.ai/papers/10.3390/biomedicines10051020
The paper
Errafii, K., Khalifa, O., Al-Akl, N. S., & Arredouani, A. (2022). Comparative Transcriptome Analysis Reveals That Exendin-4 Improves Steatosis in HepG2 Cells by Modulating Signaling Pathways Related to Lipid Metabolism. Biomedicines. https://doi.org/10.3390/biomedicines10051020

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.